Skip to main content
OpenTrials
Completed

NCT Number: NCT01469754

Longitudinal Survey Analysis in Lymphoma Survivors

Posttraumatic Stress Disorder (PTSD) is a well-documented phenomenon that occurs in cancer survivors. PTSD is known to cause problems with anxiety, depression, and quality of life. Furthermore, there is little treatment available for cancer survivors who suffer from PTSD.

Posttraumatic Growth, however, is a lesser known phenomenon that also occurs in cancer survivors. It is a positive psychological phenomenon that occurs in some people who have suffered a traumatic event--the people who are able to note a "greater appreciation for life", a "stronger relationship with their family/friends," or a "new found level of spirituality" are examples of instances of posttraumatic growth.

Coping with Lymphoma to Enhance Adjustment and Reduce Stress in Survivors (CLEAR Stress) is a study designed to compare the development of PTSD versus the development of Posttraumatic Growth in lymphoma patients at any stage of the cancer experience, regardless of treatment. The hypothesis is that posttraumatic growth, if it is significant, can reduce the impact of PTSD symptoms in the survivor.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lymphoma Coping Hemic and Lymphatic Diseases Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Mental Disorders Neoplasms Neoplasms by Histologic Type Posttraumatic Growth Posttraumatic Stress Disorder Resilience Stress Disorders, Post-Traumatic Stress Disorders, Traumatic Trauma and Stressor Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

New York Presbyterian/Weill Cornell Center for Lymphoma and Myeloma

New York, 10065, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of Lymphoma (includes Waldenstrom's Macroglobulinemia)
  • Can read/write/understand English without a translator

Exclusion criteria

  • Currently Hospitalized
  • Active Psychosis

Treatment and study plan

Primary outcomes

  1. Posttraumatic Growth

    Time frame: Measured at enrollment

Secondary outcomes

  1. Posttraumatic Stress Disorder (PTSD)

    Time frame: Measured at Enrollment

Sponsors and collaborators

Lead sponsor

Weill Medical College of Cornell University

Other

Registry information

Official study title

Coping With Lymphoma to Enhance Adjustment and Reduce Stress in Lymphoma Survivors

Acronym: CLEAR Stress

Important dates

Study start
2011
Primary completion
2013
Study completion
2013
First posted
Nov 10, 2011
Registry last updated
May 5, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.